DexCom Inc (DXCM)

DexCom News & Analysis

• 

  DexCom Prices Upsized $1.1B Notes Offering

  DexCom (DXCM) announced today the pricing of its offering of $1.1 billion aggregate principal amount of 0.375% Convertible Senior Notes due 2028 (the “notes”) in a private placement to...

• 

  DexCom Announces Proposed $1B Notes Offering

  DexCom , Inc. (Nasdaq: DXCM) (“Dexcom”) announced today that it intends to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of Convertible...

• 

  Barclays maintains DexCom at Equalweight, PT $115.00

  A Barclays analyst maintained DexCom (NASDAQ: DXCM) at Equalweight and a price target of $115.00 from a prior price target of %currency%%price%. Prior to this rating, DexCom had 17 buy...

• 

  JPMorgan maintains DexCom at Overweight, PT $150.00

  A JPMorgan analyst maintained DexCom (NASDAQ: DXCM) at Overweight and a price target of $150.00 from a prior price target of %currency%%price%. Prior to this rating, DexCom had 17 buy...

• 

  BTIG maintains DexCom at Buy, PT $134.00

  A BTIG analyst maintained DexCom (NASDAQ: DXCM) at Buy and a price target of $134.00 from a prior price target of %currency%%price%. Prior to this rating, DexCom had 17 buy ratings, 3 hold...

• 

  DexCom earnings beat by $0.02, revenue topped estimates

  Investing.com - DexCom (NASDAQ: DXCM) reported first quarter EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $741.5M versus the consensus...

• 

  Physician Checks And Latest Script Data Support DexCom Growth Opportunity: Bullish Analyst Upgrades Stock

  Raymond James analyst Jayson Bedford upgraded DexCom Inc (NASDAQ: DXCM) to Strong Buy from Outperform and increased the price target to $138 from $127.   The analyst expects an acceleration...

• 

  Raymond James upgrades DexCom to Strong Buy

  A Raymond James analyst upgraded DexCom (NASDAQ: DXCM) from Outperform to Strong Buy with a price target of $138.00 from a prior price target of %currency%%price%. Prior to this rating,...

• 

  : DexCom started at buy with $142 stock price target at UBS

  This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about...

• 

  UBS new coverage DexCom Buy

  An UBS analyst initiated new coverage DexCom (NASDAQ: DXCM) Buy rating and a price target of $142.00. Prior to this rating, DexCom had 16 buy ratings, 3 hold ratings, and 1 sell...

• 

  DexCom has no material exposure to SVB

  DexCom , Inc. (DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article:“Dexcom does not...

• 

  DexCom drops after Abbott's diabetes sensors cleared for insulin delivery system integration

  By Sam Boughedda DexCom Inc (NASDAQ:DXCM) shares are down more than 8% Monday afternoon after Abbott Laboratories (NYSE:ABT) announced that the U.S. Food and Drug Administration...

• 

  DexCom shares gain as Medicare to expand CGM coverage in April

  By Sam Boughedda DexCom Inc (NASDAQ:DXCM) shares jumped more than 6% Thursday after it was revealed that Medicare will cover continuous glucose monitors (CGMs) for a wider group of...

• 

  Apple makes non-invasive glucose monitoring breakthrough - Bloomberg

  By Sam Boughedda Apple (NASDAQ:AAPL) believes it could eventually bring a non-invasive and continuous blood glucose monitoring product to market after hitting major milestones, Bloomberg...

• 

  DexCom Tops Q4 EPS by 7c

  DexCom (DXCM) reported Q4 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2 million versus the consensus estimate of $809.35...

• 

  DexCom earnings beat by $0.07, revenue topped estimates

  Investing.com - DexCom (NASDAQ: DXCM) reported fourth quarter EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2M versus the consensus...

• 

  Stock market today: Dow pares gains to close lower as slump in health care bites

  By Yasin Ebrahim Investing.com -- The Dow gave up gains to close lower Monday, as falling health care and energy stocks offset tech strength in tech after Treasury yields slipped amid...

• 

  After-Hours Movers: Amazon Sinks on Lower Guidance, Pinterest Up on Beat

  After-Hours Stock Movers: Amazon.com (NASDAQ:AMZN) 14% LOWER; {{erl-6435||reported Q3 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $127.1...

• 

  DexCom Tops Q3 EPS by 4c

  DexCom (DXCM) reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74...

• 

  DexCom Surges as CGM Market Could be Doubled on New Medicare Proposal

  By Investing.com Staff Shares of DexCom (NASDAQ:DXCM) are 8% higher in early trading Friday after Medicare issued a Local Coverage Decision (LCD) proposal on Thursday for continuous...

• 

  Citi Opens a Positive Catalyst Watch on DexCom, Negative on Nevro, Cuts Penumbra to Neutral

  By Senad Karaahmetovic Citi analysts made a series of changes in the firm’s coverage of Medical Supplies and Technology ahead of the Q3 earnings season. Overall, they see...

• 

  BofA Outlines Top 10 U.S. Ideas for Q4 - Overall Remains Tactically Bearish

  By Sam Boughedda BofA Securities released a research paper to clients Monday outlining the firm's top ten U.S. ideas for the fourth quarter. The list includes nine Buys and one Underperform...

• 

  Stock Market Today: Dow Falls on Caterpillar Slump, Rising Geopolitical Tensions

  By Yasin Ebrahim Investing.com -- The Dow fell Tuesday, weighed down by rising geopolitical tensions and a slip in Caterpillar on weaker-than-expected revenue. The Dow Jones Industrial...

• 

  S&P 500 in Wild Swings as Yields Jump on Hawkish Fed Speak, Geopolitical Tensions

  By Yasin Ebrahim Investing.com -- The S&P 500 swung between gains and losses Tuesday, on rising geopolitical tensions and a surge in U.S. Treasury yields as Federal Reserve members...

• 

  DexCom Tumbles 12% After Earnings Miss, Analysts Say Plunge 'Greatly Exaggerated'

  By Senad Karaahmetovic Shares of DexCom Inc (NASDAQ:DXCM) plunged more than 12% in premarket Friday following weaker-than-expected Q2 results. {{erl-15951||DexCom reported an adjusted...

• 

  Pre-Open Movers: Amazon, Apple Gain on Results; Intel Plummets on Disappointment

  Pre-Open Stock Movers: Roku (NASDAQ:ROKU) 26% LOWER; {{erl-1050149||reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4...

• 

  Dow Futures Flat, Apple and Amazon Report

  By Oliver Gray Investing.com - U.S. stock futures were mostly higher during Thursday’s evening deals following a positive session for major benchmark indices as major technology...

• 

  After-Hours Movers: Amazon, Apple Gain Post EPS; Roku, Intel Plunge

  After-Hours Stock Movers: {{erl-1050149||Roku (NASDAQ:ROKU) 25% LOWER; reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4...

• 

  DexCom Misses Q2 EPS by 2c

  DexCom (DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45...

• 

  Top 5 Things to Watch in Markets in the Week Ahead - Fed Rate Hike, Earnings Flood

  By Daniel Shvartsman Investing.com - Central Banks and earnings will continue to dominate the week ahead. After the European Central Bank announced an unexpectedly hawkish 50 basis point...

• 

  U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.33%

  Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Basic Materials and Consumer Services sectors propelled shares higher. At the close in NYSE,...

• 

  Insulet Dives After Dexcom Says it is Not in Merger Discussions

  By Sam Boughedda Shares of insulin delivery device maker Insulet (NASDAQ:PODD) have tumbled 12% in early trading Tuesday following a statement from Dexcom (NASDAQ:DXCM) regarding rumors of...

• 

  Pre-Open Stock Movers 05/31: TherapeuticsMD, CatchMark Timber Trust, Yamana Gold Jump on Takeovers; Insulet Falls as Takeover Rumor Denied (more...)

  Pre-Open Stock MoversTherapeuticsMD, Inc. (NASDAQ:TXMD) 337% HIGHER; entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners for $10 per...

• 

  U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.15%

  Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Utilities, Telecoms and Oil & Gas sectors propelled shares higher while losses in the Technology, Consumer...

• 

  Midday Stock Movers: Beyond Meat, Snap, Zoom

  By Sam Boughedda Investing.com -- Yesterday's rise has been short-lived as U.S. equities slide again Tuesday. Here are your midday movers on May 24th. Snap Inc (NYSE:SNAP) stock has...

• 

  Pre-Open Stock Movers 05/24: Snap's Warning Sends Tech Stocks Reeling; Insulet Gains on Deal Talk (more...)

  Pre-Open Stock Movers:Snap (NYSE:SNAP) 34% LOWER; warns for Q2. The company said since they issued guidance on April 21, 2022, the macroeconomic environment has deteriorated further and...

• 

  Dexcom Reportedly in Talks to Acquire Insulet, Analyst Cautious

  By Senad Karaahmetovic Dexcom (NASDAQ:DXCM) is in talks to buy out diabetes device maker Insulet Corp (NASDAQ:PODD), according to Bloomberg. The two companies are currently negotiating...

• 

  DexCom Misses Q1 EPS by 20c

  DexCom (DXCM) reported Q1 EPS of $0.32, $0.20 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $628.8 million versus the consensus estimate of $624.47...

• 

  U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.65%

  Investing.com – U.S. equities were higher at the close on Friday, as gains in the Technology, Telecoms and Consumer Services sectors propelled shares higher. At the close in NYSE, the Dow...

• 

  Insulet Surges After FDA Clears Automated Insulin Delivery Product

  By Sam Boughedda Investing.com — Shares of insulin pump technology firm Insulet Corporation (NASDAQ:PODD) surged more than 15% Friday after it said the U.S. Food and Drug Administration has...

• 

  U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.26%

  Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Utilities, Basic Materials and Consumer Services sectors propelled shares higher while losses in the...

• 

  Stocks - U.S. Futures Rise after Midterm Election Results

  Investing.com – U.S. futures jumped on Wednesday, as midterm elections played out as expected, with Congress split after Democrats won the House of Representatives but Republicans kept...

• 

  U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.03%

  Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Technology, Consumer Goods and Consumer Services sectors propelled shares higher while losses in the Basic...

• 

  U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.18%

  Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Basic Materials, Utilities and Financials sectors propelled shares higher. At the close in NYSE, the Dow...

• 

  US STOCKS-Wall St opens lower after economic data

  * Q2 GDP up 3.1 pct vs. prior est. of 3.0 pct * U.S. jobless claims rise more than expected * Accenture slips after reporting results * Indexes lower: Dow 0.16 pct, S&P 0.10 pct,...

• 

  US STOCKS-Wall St set to open lower after economic data

  * Q2 GDP up 3.1 pct vs. prior est. of 3.0 pct * U.S. jobless claims rise more than expected * Accenture slips after reporting results * Futures lower: Dow 45 pts, S&P 4.5 pts, Nasdaq...

• 

  US STOCKS-Futures flat ahead of GDP, jobs data

  * Futures lower: Dow 18 pts, S&P 1.5 pts, Nasdaq 6.25 pts By Sruthi Shankar Sept 28 (Reuters) - U.S. stock index futures were little changed on Thursday as investors assessed the new...

• 

  U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.03%

  Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Industrials, Financials and Technology sectors propelled shares higher while losses in the Oil & Gas, Basic...